40808-63-7

Basic information

• Product Name: 2-(2-ISOTHIOCYANATOETHYL)THIOPHENE
• Synonyms: 2-(2-ISOTHIOCYANATOETHYL)THIOPHENE;thiophene, 2-(2-isothiocyanatoethyl)-
• CAS NO: 40808-63-7
• Molecular Formula: C7H7NS2
• Molecular Weight: 169.26718
• Mol File: 40808-63-7.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(2-ISOTHIOCYANATOETHYL)THIOPHENE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-ISOTHIOCYANATOETHYL)THIOPHENE(40808-63-7)
• EPA Substance Registry System: 2-(2-ISOTHIOCYANATOETHYL)THIOPHENE(40808-63-7)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 40808-63-7(Hazardous Substances Data)

Usage

Structure

A thiophene ring with an isothiocyanate functional group attached to a two-carbon chain

Type of compound

Thiophene derivative

Potential applications

Organic synthesis, pharmaceuticals

Possible properties

Unique structure and reactivity, potential biological activity

Research interest

Medicinal chemistry, material science

Versatility

Potential applications in various industries

Upstream product

• 30433-91-1 [2-(2-thyenyl)ethyl]amine 
• 6160-65-2 1,1'-Thiocarbonyldiimidazole 
• 53356-40-4 C₇H₉NS₃ 

Relevant articles and documents

N 1-2-THIOPHENE-2-YLETHYL-N2-SUBSTITUTED BIGUANIDE DERIVATE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENTS

The present invention provides an N1-2-thiophen-2-ylethyl-N2-substituted biguanide derivative of formula (I) or a pharmaceutically acceptable salt thereof, a method for preparing same, and a pharmaceutical composition comprising same as an active ingredient. The inventive N1-2-thiophen-2-ylethyl-N2-substituted biguanide derivative exhibits improved blood glucose level- and lipid level-lowering effects even with a reduced dosage as compared to conventional drugs, and thus, it is useful for preventing or treating diabetes, metabolic syndromes such as insulin-independent diabetes, obesity and atherosclerosis, or a P53 gene defect-related cancer.